Long-term variability of CO2 and O in the Mars upper atmosphere from MRO radio science data

We estimate the annual variability of CO2 and O partial density using approximately 6years of Mars Reconnaissance Orbiter (MRO) radio science data from August 2006 to January 2012, which cover three full Martian years (from the northern hemisphere summer of 28 to the northern hemisphere summer of 31). These two elements are the dominant species at the MRO periapsis altitude, constituting about 70-80% of the total density. We report the recovered annual cycle of CO2 and the annual and seasonal cycle of O in the upper atmosphere. Although no other observations are available at those altitudes, our results are in good agreement with the density measurements of the Mars Express Spectroscopy for Investigation of Characteristics of the Atmosphere of Mars, which uses stellar occultations between 60 and 130km to determine the CO2 variability, and with the Mars Global Reference Atmospheric Model 2010 for the O annual and seasonal variabilities. Furthermore, the updated model provides more reasonable MRO drag coefficients (CD), which are estimated to absorb mismodeling in the atmospheric density prediction. The higher content of dust in the atmosphere due to dust storms increases the density, so the CDs should compensate for this effect. The correlation between the drag coefficient and the dust optical depth, measured by the Mars Odyssey Thermal Emission Imaging System (THEMIS) instrument, increases from 0.4 to 0.8 with the a priori and adjusted models, respectively. The trend of CDs not only confirms a substantial improvement in the prediction of the atmospheric density with the updated model but also provides useful information for local dust storms, near MRO periapsis, that cannot be measured by the opacity level since THEMIS does not always sample the southern hemisphere evenly

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

Metastasis continues to be the primary cause of all cancer-related deaths despite the recent advancements in cancer treatments. To evaluate the role of mutations in overall survival (OS) and treatment outcomes, we analyzed 957 metastatic patients with seven major cancer types who had available molecular testing results with a FoundationOne CDx® panel. The most prevalent genes with somatic mutations were TP53, KRAS, APC, and LRP1B. In this analysis, these genes had mutation frequencies higher than in publicly available datasets. We identified that the somatic mutations were seven mutually exclusive gene pairs and an additional fifty-two co-occurring gene pairs. Mutations in the mutually exclusive gene pair APC and CDKN2A showed an opposite effect on the overall survival. However, patients with CDKN2A mutations showed significantly shorter OS (HR: 1.72, 95% CI: 1.34–2.21, p \u3c 0.001) after adjusting for cancer type, age at diagnosis, and sex. Five-year post metastatic diagnosis survival analysis showed a significant improvement in OS (median survival 28 and 43 months in pre-2015 and post-2015 metastatic diagnosis, respectively, p = 0.00021) based on the year of metastatic diagnosis. Although the use of targeted therapies after metastatic diagnosis prolonged OS, the benefit was not statistically significant. However, longer five-year progression-free survival (PFS) was significantly associated with targeted therapy use (median 10.9 months (CI: 9.7–11.9 months) compared to 9.1 months (CI: 8.1–10.1 months) for non-targeted therapy, respectively, p = 0.0029). Our results provide a clinically relevant overview of the complex molecular landscape and survival mechanisms in metastatic solid cancers

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients

Metastasis continues to be the primary cause of all cancer-related deaths despite the recent advancements in cancer treatments. To evaluate the role of mutations in overall survival (OS) and treatment outcomes, we analyzed 957 metastatic patients with seven major cancer types who had available molecular testing results with a FoundationOne CDx® panel. The most prevalent genes with somatic mutations were TP53, KRAS, APC, and LRP1B. In this analysis, these genes had mutation frequencies higher than in publicly available datasets. We identified that the somatic mutations were seven mutually exclusive gene pairs and an additional fifty-two co-occurring gene pairs. Mutations in the mutually exclusive gene pair APC and CDKN2A showed an opposite effect on the overall survival. However, patients with CDKN2A mutations showed significantly shorter OS (HR: 1.72, 95% CI: 1.34–2.21, p \u3c 0.001) after adjusting for cancer type, age at diagnosis, and sex. Five-year post metastatic diagnosis survival analysis showed a significant improvement in OS (median survival 28 and 43 months in pre-2015 and post-2015 metastatic diagnosis, respectively, p = 0.00021) based on the year of metastatic diagnosis. Although the use of targeted therapies after metastatic diagnosis prolonged OS, the benefit was not statistically significant. However, longer five-year progression-free survival (PFS) was significantly associated with targeted therapy use (median 10.9 months (CI: 9.7–11.9 months) compared to 9.1 months (CI: 8.1–10.1 months) for non-targeted therapy, respectively, p = 0.0029). Our results provide a clinically relevant overview of the complex molecular landscape and survival mechanisms in metastatic solid cancers

Time variations of Mars' gravitational field and seasonal changes in the masses of the polar ice caps

Tracking of the Mars Global Surveyor spacecraft has been used to measure changes in the long-wavelength gravity field of Mars and to estimate the seasonal mass of carbon dioxide that is deposited in the polar regions each fall and winter and sublimed back into the atmosphere every spring and summer. Observations spanning 4 Mars years have been analyzed. A clear and well-defined seasonal signal, composed of annual and semiannual periods, is seen in the lowest odd degree 3 coefficient but with less confidence in the lowest even degree 2, which is expected to be smaller and is also much more difficult to observe. Direct estimation of the seasonal mass exchange employing a simple, seasonally varying model of the size and height of each cap provides values that indicate some systematic departures from the deposition predicted by a general circulation model. Estimates are also obtained for the precession and nutation of the pole of rotation of Mars, the degree 2 tidal Love number, k 2, and the mass of Phobos, the larger of Mars' two natural satellites.United States. National Aeronautics and Space Administration (Mars Global Surveyor Project, NASA Mars Program

Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.

International audienceBackground and objective Dysferlinopathies are a group of muscle disorders caused by mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern of muscle involvement in smaller patient cohorts, but a large imaging study across the entire spectrum of the dysferlinopathies had not been performed and previous imaging findings were not correlated with functional tests.Methods We present cross-sectional T1-weighted muscle MRI data from 182 patients with genetically confirmed dysferlinopathies. We have analysed the pattern of muscles involved in the disease using hierarchical analysis and presented it as heatmaps. Results of the MRI scans have been correlated with relevant functional tests for each region of the body analysed.Results In 181 of the 182 patients scanned, we observed muscle pathology on T1-weighted images, with the gastrocnemius medialis and the soleus being the most commonly affected muscles. A similar pattern of involvement was identified in most patients regardless of their clinical presentation. Increased muscle pathology on MRI correlated positively with disease duration and functional impairment.Conclusions The information generated by this study is of high diagnostic value and important for clinical trial development. We have been able to describe a pattern that can be considered as characteristic of dysferlinopathy. We have defined the natural history of the disease from a radiological point of view. These results enabled the identification of the most relevant regions of interest for quantitative MRI in longitudinal studies, such as clinical trials